In contrast to IgG and IgM, children who developed MIS-C had significantly higher IgA antibody responses (Figure 1A, right panel) directed against RBD, S1 and triS (p=0.0042), but not against S2 and N antigens compared to control children. This evidence concerns the gene CD79A and COVID-19–associated multisystem inflammatory syndrome in children.